BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Activaero's Watchhaler Receives FDA (JOBS) 510(K) Clearance


7/16/2008 7:16:04 AM

Gemnden, Germany, July 16, 2008 –Activaero GmbH, the world leader in controlled breathing technologies for inhaled therapeutic agents, today announced that the US Food and Drug Administration (FDA) has issued 510(K) clearance for the Company’s Watchhaler? spacer, a revolutionary inhalation concept for children. The 510(k) clearance allows Activaero to market the Watchhaler? device in the US. Watchhaler? was previously launched in Europe in April of last year.

Dr Gerhard Scheuch, Founder and CEO of Activaero commented: “Childhood asthma is a growing problem on both sides of the Atlantic and parents need reliable spacers to ensure their children get the right doses of asthmatic medication. The Watchhaler? makes supervision easier for the parent, inhalation more fun for the child and dosing of medication more controlled and accurate. We are delighted to be able to bring this revolutionary spacer to the US Market.”

Watchhaler™ is a reservoir system, or ‘spacer’, controlling the inhalation flow rate and volume to target the aerosol specifically to the lung region, where the drug is needed. This system is particularly tailored to the needs of child patients using asthma medication. The child friendly Watchhaler™ spacer is designed for use with standard metered dose inhalers (MDIs) of the kind often used for inhaled medication.

Activaero is the world leader in controlled breathing technologies for inhaled therapeutic agents. With stand alone inhalation products and inhalation systems available for clinical trials and marketing partnerships, Activaero’s technologies allow for the most precise and efficient patient-tailored pulmonary delivery. Activaero currently has two products on the market, AKITA?, a patient-tailored controlled breathing system with a smartcard that records the patient dosing parameters, and Watchhaler™, a hand held delivery system tailored specifically to children. The Company also has available a range of technologies ideal for the controlled delivery of inhaled therapeutics in the clinical trial setting and tailored to specific partnerships (AKITA2?, LimiX™). Finally, Activaero works with partners on a consultancy basis in the development of ideal inhaled delivery systems and the logistics in clinical trials. Activaero’s technological approach has been validated repeatedly in the clinical setting. The Company is privately held and located in Gem?nden (Wohra) and Munich in Germany and Dublin, Ohio in the USA.

Further Information:

Axel Fischer Activaero GmbH Phone: +49 (0) 6453 64818-0 E-Mail: fischer@activaero.de

William C. Zimlich Activaero America, Inc. Phone: +1 (614) 761 3555 E-Mail: zimlich@activaero.com Dr. Douglas Pretsell Account Director, Munich Bureau Chief

College Hill Phone : +49 (0)89 57 00 18 06 E-Mail: douglas.pretsell@collegehill.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES